Stocks · Health care · Pharmaceutical Preparations

uniQure N.V.

QURE Clue Score22
Fiscal year ends December CIK 0001590560 Results filed 4 Nov 2026

What the insiders did No buying or selling

By person

12 insiders · 0 transactions
35.2×

Matthew Kapusta holds 35.2 times base salary in stock. $23.83M of shares against $676.17K in salary for 2025.

Salary from the company's own proxy. The shares are what Matthew Kapusta last reported holding, valued at $45.89, the price Ordinary Shares was last bought or sold at on the open market here, on 2 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Matthew C Kapusta
CEO, Managing Director
—
—
—
519,227
0.7485%
$23.83M
−12.1%
Christian Klemt
Chief Financial Officer
—
—
—
226,581
0.3266%
$10.40M
+37.5%
Walid Abi-Saab
Chief Medical Officer
—
—
—
166,985
0.2407%
$7.66M
+44.9%
Jeannette Potts
Chief Legal Officer
—
—
—
133,246
0.1921%
$6.11M
+45.1%
Kylie O'Keefe
Chief Customer & Strat Officer
—
—
—
108,864
0.1569%
$5.00M
+3.7%
Madhavan Balachandran
Director
—
—
—
43,254
0.0624%
$1.98M
+35.9%
Jeremy P. Springhorn
Director
—
—
—
43,251
0.0624%
$1.98M
+35.9%
David D. Meek
Director
—
—
—
39,747
0.0573%
$1.82M
+40.3%
Leonard E Post
Director
—
—
—
35,494
0.0512%
$1.63M
+47.4%
Rachelle Suzanne Jacques
Director
—
—
—
33,903
0.0489%
$1.56M
+50.8%
Robert Gut
Director
—
—
—
32,259
0.0465%
$1.48M
−36.9%
Jack Kaye
Director
—
—
—
25,996
0.0375%
$1.19M
+78.3%